Kevin Kris Warnakula Olesen

MD PhD FESC, postdoctoral fellow, Gødstrup Regional Hospital & Aarhus University Hospital. Epidemiology, diabetes & coronary artery disease.

[European Society of Cardiology Journals @ESC_Journals]

Net clinical benefit of #DPI with low-dose #rivaroxaban consistently observed in CAD patients at low, moderate or high CV risk: Data from the COMPASS trial in #EHJPharmacotherapy 👉 https://t.co/SQ7nUzlkRK

@DLBHATTMD @mirvatalasnag @FeliceGragnano @EditorEHJCVP

[Department of Cardiology Research AUH @AUHCardio]

🫀New publication in @JACCJournals by @CGyldenkerne et al.

👩‍🎓 Young patients with newly diagnosed #type2diabetes have the highest relative risk of #CVD

📷 Indicate an unmet need for optimized prophylactic treatment!

@MichaelMaeng1 @dr_rwt

link: https://t.co/sAy6e8gaZ3

[Dagens Medicin @DagensMedicinDK]

Patienter med akut blodprop i hjertet, der overlever de første 90 dage, har ingen overdødelighed sammenlignet med den øvrige befolkning, viser dansk undersøgelse præsenteret på #ESCCongress2023 #sundpol
https://t.co/x79ht2RRua

[Danish Cardiovascular Academy @DCAcademyDK]

CONGRATULATIONS TO OUR NEW SCIENCE AMBASSADORS 2023🤩📷Together with @gunngis from the @Hjerteforening we had the privilege of appointing 20 new science ambassadors this Wednesday. We wish the young researchers good luck on their research journey.
@novonordisk

[Felice Gragnano @FeliceGragnano]

#Statins but NOT #aspirin reduced CV risk in #diabetes patients without obstructive CAD: new observational evidence from a large 🇩🇰 study 💊⤵️
https://t.co/h6SZpnAYO5
#EHJPharmacotherapy @AgewallStefan
#CardioTwitter #ESCYoung @escardio @ESC_Journals @KrisWarnakula @MichaelMaeng1

[Department of Cardiology Research AUH @AUHCardio]

At #ESCCongress @KrisWarnakula just presented a large study examining wether diabetes remains a cardiovascular risk equivalent to #CHD

@escardio #ESC2022

Watch this clip for the main results 👇🏻

[Thomas Jensen @thjendk]

Read our newest study in @EJCI_News!🎉 https://t.co/4xtQiLhnFf
Guideline implementation of the CHA2DS2-VASC score was associated with increased use of triple therapy and a decline in ischemic outcomes. Paradoxically, risk of bleeding remained constant @AUHCardio @michael_maeng

[Department of Cardiology Research AUH @AUHCardio]

PhD student @GroThrane presented her study on #Ticagrelor implementation in PCI-treated #ACS patients at #ESCCongress 💊

Watch on demand 👉 https://t.co/x10jNL7e3o

@escardio #CardioTwitter

[Department of Cardiology Research AUH @AUHCardio]

At the session Latest science in CV prevention at #ESCCongress, PhD student Christine Gyldenkerne presented her study "Nationwide trends in stroke and #AF in patients with incident DM2" 🫀🧠

Watch on demand 👉 https://t.co/ajITFvqeCL

@escardio @dceaarhus #CardioTwitter

[Department of Cardiology Research AUH @AUHCardio]

Watch the presentation on refining dual antithrombotic treatment in patients with #CCS by @KrisWarnakula at the session Latest Science in ACS #ESCCongress 🫀

👉 https://t.co/YRsBJdeAUL

@escardio #CardioTwitter

[Department of Cardiology Research AUH @AUHCardio]

A study from the Western Denmark Heart Registry by @KrisWarnakula et al., demonstrates that #diabetes increases the risk of limb amputations 🦵 by 5.5-fold in patients without coronary artery disease. Continued risk management is needed!

https://t.co/aRMFSJ1GNy

[Department of Cardiology Research AUH @AUHCardio]

In this study by @KrisWarnakula et al., myocardial infarction🫀, ischemic stroke🧠, and cardiac death ⬇️ by up to 62% in patients with chronic coronary syndrome from 2004 to 2016. Likely caused by major improvements in treatment of CAD💊💉
https://t.co/IXjeQFmBbv

[Department of Cardiology Research AUH @AUHCardio]

In this study, @KrisWarnakula et al. found, that diabetes ptts without CAD have the same low 10-year risk of MI as the general population. However, they remain at increased risk of ischemic stroke and death 🧠⚰️
Still room for improvement!

https://t.co/LA9KAEi9ka

[European Society of Cardiology Journals @ESC_Journals]

Real-world data on the temporal trend in 2-yr CV risk of patients with chronic coronary syndrome and angiographic #CAD: we're on the right path! https://t.co/wwfVa9hrEB

#EHJQCCO #cardiotwitter #MI @adamtimmis @diogoasantosfer